Literature DB >> 19440044

ATR kinase as master regulator of nucleotide excision repair during S phase of the cell cycle.

Yannick Auclair1, Raphael Rouget, Elliot A Drobetsky.   

Abstract

Nucleotide excision repair (NER) is a major determinant in cancer development and treatment via its essential role in eliminating highly-genotoxic, helix-distorting DNA adducts that block replication and transcription. Over the years, many elegant studies employing UV as model mutagen have led to a detailed understanding of how the NER pathway itself is coordinated. Nonetheless relatively little is known regarding any precise functions of various preeminent mutagen-responsive signaling cascades lying upstream of NER, notably those mediated by the canonical MAPKs or the PIKK family members ATR and ATM. Here we present a brief overview of NER, mostly in the context of studies on human cells treated with UV, and describe recent results from our laboratory which have significantly elucidated the role of UV-induced signal transduction in this repair pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440044     DOI: 10.4161/cc.8.12.8800

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

1.  Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy.

Authors:  Vaibhav Murthy; Dalton Dacus; Monica Gamez; Changkun Hu; Sebastian O Wendel; Jazmine Snow; Andrew Kahn; Stephen H Walterhouse; Nicholas A Wallace
Journal:  J Vis Exp       Date:  2018-06-08       Impact factor: 1.355

2.  A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication.

Authors:  Xiaofei E; George Savidis; Christopher R Chin; Shixia Wang; Shan Lu; Abraham L Brass; Timothy F Kowalik
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.

Authors:  S Beesetti; J Mavuluri; R P Surabhi; T M Oberyszyn; K Tober; R S Pitani; L D Joseph; G Venkatraman; S K Rayala
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

4.  Differential DNA damage responses in p53 proficient and deficient cells: cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells.

Authors:  Zhengke Li; Phillip R Musich; Yue Zou
Journal:  Int J Biochem Mol Biol       Date:  2011-04-15

5.  The role of XPC: implications in cancer and oxidative DNA damage.

Authors:  Joost P M Melis; Mirjam Luijten; Leon H F Mullenders; Harry van Steeg
Journal:  Mutat Res       Date:  2011-07-07       Impact factor: 2.433

6.  Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-03       Impact factor: 4.355

Review 7.  Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress.

Authors:  Shan Yan; Melanie Sorrell; Zachary Berman
Journal:  Cell Mol Life Sci       Date:  2014-06-20       Impact factor: 9.261

Review 8.  Ras signaling through RASSF proteins.

Authors:  Howard Donninger; M Lee Schmidt; Jessica Mezzanotte; Thibaut Barnoud; Geoffrey J Clark
Journal:  Semin Cell Dev Biol       Date:  2016-06-08       Impact factor: 7.727

9.  ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways.

Authors:  Elizabeth A Fedak; Frederick R Adler; Lisa M Abegglen; Joshua D Schiffman
Journal:  Bull Math Biol       Date:  2021-03-11       Impact factor: 1.758

10.  ATR prevents Ca2+ overload-induced necrotic cell death through phosphorylation-mediated inactivation of PARP1 without DNA damage signaling.

Authors:  Zhengke Li; Hui Wang-Heaton; Brian M Cartwright; Yetunde Makinwa; Benjamin A Hilton; Phillip R Musich; Nikolozi Shkriabai; Mamuka Kvaratskhelia; Shengheng Guan; Qian Chen; Xiaochun Yu; Yue Zou
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.